Showing results (121-130 of 6,998) with videos related to
Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|December 29, 2020
Cancer treatment in the coronavirus disease pandemicJia-Tao Zhang, Wen-Zhao Zhong, Yi-Long WuLung Cancer (Amsterdam, Netherlands)|December 7, 2019
Newly diagnosed patients with advanced non-small cell lung cancer: A clinical description of those with moderate to severe depressive symptomsB L Andersen, T R Valentine, S B Lo, et al.Lung Cancer (Amsterdam, Netherlands)|September 22, 2020
Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III studyJonathan W Goldman, Marina Chiara Garassino, Yuanbin Chen, et al.Lung Cancer (Amsterdam, Netherlands)|September 24, 2020
Spectrum of uncommon and compound epidermal growth factor receptor mutations in non-small-cell lung carcinomas with treatment response and outcome analysis: A study from IndiaVarsha Singh, Aruna Nambirajan, Prabhat Singh Malik, et al.Lung Cancer (Amsterdam, Netherlands)|April 3, 2020
Favorable incremental cost-effectiveness ratio for lung cancer screening in ItalyGiulia Veronesi, Niccolò Navone, Pierluigi Novellis, et al.Lung Cancer (Amsterdam, Netherlands)|August 29, 2020
Exploring imaging features of molecular subtypes of large cell neuroendocrine carcinoma (LCNEC)B C M Hermans, S Sanduleanu, J L Derks, et al.Lung Cancer (Amsterdam, Netherlands)|March 24, 2020
Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancerMasato Karayama, Nobuko Yoshizawa, Masataka Sugiyama, et al.Lung Cancer (Amsterdam, Netherlands)|March 23, 2020
Prognostic significance of microscopic size in peripherally located scar-associated clinical stage I lung carcinomasHumberto E Trejo Bittar, Jacob A Jerome, Douglas Hartman, et al.Lung Cancer (Amsterdam, Netherlands)|March 23, 2020
Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohortMateo Sanchis-Borja, Charles Ricordel, Anne Marie Chiappa, et al.Lung Cancer (Amsterdam, Netherlands)|January 27, 2020
Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with EGFR sensitive mutant non-small cell lung cancer in a Real world populationLiang Zeng, Lili Xiao, Wenjuan Jiang, et al.Pageof 700